Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular dystrophy
US8450281B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2008 |
| Grant date | May 28, 2013 |
| Priority date | — |
| Expiry date | Apr 14, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P21/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of a nonimmunosuppressive cyclosporin A derivative for reducing mitochondrial dysfunction and the rate of apoptosis of muscle cells of patients diagnosed with Ullrich congenital muscular dystrophy or Bethlem myopathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.